Promoter Bank clone, Human bone morphogenetic protein 6 (BMP6) promoter
Alternative name | p1882-5F |
---|---|
Clone info. | The Human bone morphogenetic protein 6 (BMP6) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 7725636 to 7726955(NC_000006.12); relatively -463 to +857, where +1 corresponds to 1 nt of NM_001718.5; relatively -1142 to +178, where +1 corresponds to 1 nt of NM_001718.4. |
Comment | PCR cloning forward primer, B2PB0010F: 5' ctgccgtggaaagccacgtgtcc 3'; reverse primer, B2PB0010R: 5' ccccgcccggccgggctgccc 3' Reference: Fig.2 of Tamada, H., Biochim. Biophys. Acta 1395 (3): 247-251 (1998). Entire sequence of promoter region has not been confirmed. |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human bone morphogenetic protein 6 genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05474 | pKM2L-phBMP6 | DNA solution |
Materials & Methods section:
The pKM2L-phBMP6 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05474). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB14631_A7Bsp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB14631_A7Bsa.seq |
---|
>05474_14631_A7Bs_M13(-40)_B08_02_ABI08.ab1 1 CCGGCCGTCC AGCTTGCATG CCTGCAGGTC ATTTAATAGG GATAACAGGG TAATGATTAA 61 GATCTCGAGC TCTAAGCTTC ACATATGCAT GCACTAGTGG CCTGCCGTGG AAAGCCACGT 121 GTCCGCTAAA CGCCTACATT ACATCAATAA GAGAAACTAA GGAAGGGATG GAAAAGCTAT 181 CATTTTTCTT TTCTTCCTCA GTTCTGGCAG TATAGTGATT TAATCGCTGT TATTATTTTT 241 ATTTAGTTAA AGCATCAACT TAGGCCTTTT AAATGATGGT AAAAGAGAAA GCTTCAGATC 301 GGGGTATTGG TCAGATCATT CTTACTAGCG ATGACCTCTT CGCCTTTGGC ACCTCGCGGC 361 TCTTCGCATG CCTCCAAGAA TTCCCGGGTC TTGAAACCTA CGCGCGGCGG AGGCGACGCC 421 TCTCGGGAGA GGGAGGGTGA AAGAAGGGGC GGGGCTATTT AAATAGCCCG CGAGCTTCGC 481 GTCCCCATTG GCTGCCAGCC TGTCGGTTAC CGCGGGGCGG GGAGTCCCGG GGCTGGAGTG 541 AGGTACCTGA GCCGGGCGCG CAGCAGAAAG CCCACGTTGG CCGCTGCGGG GAGCGCGGCG 601 TGGAGAGGCG GGAGACCGAA TTCCGGCGCC GCCGCCGCGG CCGCTGCTCG GTGCACTAGC 661 CCCCTTCCTT CCCATCCTTT CTGCGAGCGG GTTTGCTGGG CAGCCGGGCG ACCGCCGAAC 721 GGAAAGCAAG ATCCTCGCCG CCTCCGCTTG AGGAGGCGTG CGGCGCGCGG AGATTTTGAG 781 TGGGAGCGAC GGTGCCCGAG AGCTCAGGGG CGCGGAGTTC GTGAGCGAGA AGGAAGTTAA 841 ACCTCGCGGA ATAGACTGGC ATTTCGGGAC GCCTTGTCGC CGCAGCCTGG GCCCTGCAAC 901 GGGGTAAACT TCATGGTGGC CCTGCGATCT GGGGAGGGGC GTGCGCCACG GTGATGCCGG 961 GCATCTCCCG CAGCTCGTGA GCGGCCCCGC TCCCCGCTGC CCCGGGTCCC ACTCAGTCGC 1021 CAAGGGAGAG CGCGGGGCAG CGCACGTGTG CGGCCAGCGA GGCCCAGAGT GACCGCGCCG 1081 CGACTCGCAG GAGCCAAGGG CGCAAGGCTG CAATGGCAGC CCGGACCTCA GACGGCACCT 1141 GCCTGGAACC GCCGCGTCTT CTAGAGACCT GCGCGAGAGG CCTGTGTGAA GCTCCCTTCC 1201 TTCCCTCTCC AAGGCGGGAT CTCTCTTGGG GAGATCTC // |
Primer: phRLR2 Sequence file: RDB14631_A7Bsb.seq |
>05474_14631_A7Bs_phRLR2_E07_05_ABI08.ab1 1 AACTTTTTCC TGTCTGACAA GCCCAGTTTC TATTGGTCTC CTTAAACCTG TCTTGTAACC 61 TTGATACTTA CCTGCCCAGT GCCTCACGAC CAACTTCTGC AGTACCCGGG TGAATTCTAC 121 GCGTCGACAG GCCCCCGCCC GGCCGGGCTG CCCCCGCGGA TCCCGCGAGG CGTGGAGCGG 181 CGGAGCGAGG CCGGAGCGCG GCCGCTGTGG CCCTTGGCGT GAGCAGTCCC CGCCACCTCT 241 CGGCGGGCTC GCTTCCCCTT CCTGGCCCTC AGTCCTTATC TCTCATGGTC GTCCGGGGCG 301 CCCCCAGTTG CCCAGGCTAG AGAGGTGGCG AAGGGGCGAT CACCAGGAGA ACCGCTTGGA 361 GGGGAGGAAG GGGAGCCTCA CAGCCTCGCG CAGGTCTCTA GAGGCGCGCG GTCCAGGCCA 421 GGTGCGTCTG AGTCCGGGCT GCACTGCAGC CTGCGCCCTG GCTCCTGCGA GTCGCGGCGC 481 GGTCACTCTG GGCCTCGCTG GCCGCACACG TGCGCTGCCC CGCGCTCTCC CTGGCGACTG 541 AGTGGGACCC GGGGCAGCGG GGAGCGGGGC CGCTCACGAG CTGCGGGAGA TGCCCGGCAT 601 CACCGTGGCG CACGCCCCTC CCCAGATCGC AGGGCCACCA TGAAGTTTAC CCCGTTGCAG 661 GGCCCAGGCT GCGGCGACAA GGCGTCCCGA AATGCCAGTC TATTCCGCGA GGTTTAACTT 721 CCTTCTCGCT CACGAACTCC GCGCCCCTGA GCTCTCGGGC ACCGTCGCTC CCACTCAAAA 781 TCTCCGCGCG CCGCACGCCT CCTCAAGCGG AGGCGGCGAG GATCTTGCTT TCCGTTCGGC 841 GGTCGCCCGG CTGCCCAGCA AACCCGCTCG CAGAAAGGAT GGGAAGGAAG GGGGCTAGTG 901 CACCGAGCAG CGGCCGCGGC GGCGGCGCCG GAATTCGGTC TCCCGCCTCT CCACGCCGCG 961 CTCCCCGCAG CGGCCAACGT GGGCTTTCTG CTGCGCGCCC GGCTCAGTAC CTCACTCCAG 1021 CCCCGGGACT CCCCGGCCCG CGGTAACCGA CAGGCTGGCA GCCAATGGGG ACGCGAAGCT 1081 CGCGGGCTAT TTAAATAGCC CCGCCCCTTC TTTCACCCTC CCTCTCCGAG GAGCGTCGCC 1141 TCCGCCGCCG CGTAGTTTCA GGACCCGGAT TCTTGGAGCA TGCAGAGCCC CAGTGCAAGC 1201 GAAGTCATCG CTAGTAGAAT GATCTGGACC CATTACCCGA ATCTCTGGGA GCCTTTTC // |
Primer: pAxCALNL_F1 Sequence file: RDB14631_A7Bsc.seq |
>05474_14631_A7Bs_pAxCALNL_F1_F07_06_ABI08.ab1 1 AATAAATGTA TCTTATCATG TCTGCTCGAA GCGGCCGCTC TAGAATTACT GCTCGTTCTT 61 CAGCACGCGC TCCACGAAGC TCTTGATGTA CTTACCCATT TCATCTGGAG CGTCCTCCTG 121 GCTGAAGTGG AGGCCCTTCA CCTTCACGAA CTCGGTGTTA GGGAACTTCT TAGCTCCCTC 181 GACAATAGCG TTGGAAAAGA ACCCAGGGTC GGACTCGATG AACATCTTAG GCAGATCGTC 241 GCTGGCCCGA AGGTAGGCGT TGTAGTTGCG GACAATCTGG ACGACGTCGG GCTTGCCTCC 301 CTTAACGAGA GGGATCTCGC GAGGCCAGGA GAGGGTAGGC CGTCTAACCT CGCCCTTCTC 361 CTTGAATGGC TCCAGGTAGG CAGCGAACTC CTCAGGCTCC AGTTTCCGCA TGATCTTGCT 421 TGGGAGCATG GTCTCGACGA AGAAGTTATT CTCAAGCACC ATTTTCTCGC CCTCTTCGCT 481 CTTGATCAGG GCGATATCCT CCTCGATGTC AGGCCACTCG TCCCAGGACT CGATCACGTC 541 CACGACACTC TCAGCATGGA CGATGGCCTT GATCTTGTCT TGGTGCTCGT AGGAGTAGTG 601 AAAGGCCAGA CAAGCCCCCC AGTCGTGGCC CACAAAGATG ATTTTCTTTG GAAGGTTCAG 661 CAGCTCGAAC CAAGCGGTGA GGTACTTGTA GTGATCCAGG AGGCGATATG AGCCATTCCC 721 GCTCTTGCCG GACTTACCCA TTCCGATCAG ATCAGGGATG ATGCATCTAG CCACGGGCTC 781 GATGTGAGGC ACGACGTGCC TCCACAGGTA GCTGGAGGCA GCGTTACCAT GCAGAAAAAT 841 CACGGCGTTC TCGGCGTGCT TCTCGGAATC ATAGTAGTTG ATGAAGGAGT CCAGCACGTT 901 CATTTGCTTG CAGCGAGCCC ACCACTGAGC CCAGTGATCA TGCGTTTGCG TTGCTCGGGG 961 TCGTACACCT TGGAAGCCAT GGTGGCTAGC CTATAGTGAG TCGTATTAAG TACTCTAGCC 1021 TTAAGAGCTG TAATTGAACT GGGAGTGGAC ACCTGTGGAG AGAAGGCAAA GTGATGTCAG 1081 TAGACCATAG GTGCCTATCA GAAACGCAGA GTCTTCTCTG TTCTCGACAA GCCCAGGTTT 1141 CTATTGTCTT CTTAACTGTC TGTACCTTGA TACTACTGCC AAGTGCTCAC GACCACCTTC 1201 TGCAGTACTG TGATCTAACG CGTCGACAGG CCCCGCGCCC GGTCCGGGTG TC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
reference | Tamada, H., Molecular cloning and analysis of the 5'-flanking region of the human bone morphogenetic protein-6 (BMP-6). Biochim. Biophys. Acta 1395 (3): 247-251 (1998). PMID 9512655. |
---|---|
user_report | Ohta, K., Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation. PLoS Pathog. 19 (8): e1011591 (2023). PMID 37585449. [link to RRC of NBRP] |
Featured content